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Clinical radiation therapy for the treatment of CNS cancers leads to unintended and
debilitating impairments in cognition. Radiation-induced cognitive dysfunction is long
lasting; however, the underlying molecular and cellular mechanisms are still not well
established. Since ionizing radiation causes microglial and astroglial activation, we
hypothesized that maladaptive changes in astrocyte function might be implicated
in radiation-induced cognitive dysfunction. Among other gliotransmitters, astrocytes
control the availability of adenosine, an endogenous neuroprotectant and modulator
of cognition, via metabolic clearance through adenosine kinase (ADK). Adult rats
exposed to cranial irradiation (10 Gy) showed significant declines in performance of
hippocampal-dependent cognitive function tasks [novel place recognition, novel object
recognition (NOR), and contextual fear conditioning (FC)] 1 month after exposure to
ionizing radiation using a clinically relevant regimen. Irradiated rats spent less time
exploring a novel place or object. Cranial irradiation also led to reduction in freezing
behavior compared to controls in the FC task. Importantly, immunohistochemical
analyses of irradiated brains showed significant elevation of ADK immunoreactivity in the
hippocampus that was related to astrogliosis and increased expression of glial fibrillary
acidic protein (GFAP). Conversely, rats treated with the ADK inhibitor 5-iodotubercidin (5-
ITU, 3.1 mg/kg, i.p., for 6 days) prior to cranial irradiation showed significantly improved
behavioral performance in all cognitive tasks 1 month post exposure. Treatment with
5-ITU attenuated radiation-induced astrogliosis and elevated ADK immunoreactivity
in the hippocampus. These results confirm an astrocyte-mediated mechanism where
preservation of extracellular adenosine can exert neuroprotection against radiation-
induced pathology. These innovative findings link radiation-induced changes in cognition
and CNS functionality to altered purine metabolism and astrogliosis, thereby linking the
importance of adenosine homeostasis in the brain to radiation injury.
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INTRODUCTION
The adverse neurocognitive side effects of radiotherapy used to treat CNS cancers are
unintended and largely unavoidable. It is now well-documented that major changes occur in
the brain following exposure to clinical radiotherapy protocols, including severe morphologic
and physiological damage that coincides with substantial depletion of CNS stem cell populations
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(Monje et al., 2002; Mizumatsu et al., 2003; Rola et al., 2004;
Limoli et al., 2007; Parihar et al., 2014a). These changes occur
along with reductions in dendritic complexity and synaptic
density of more mature neurons (Parihar and Limoli, 2013;
Parihar et al., 2014b). Consequently, cranial radiotherapy causes
substantial decrements in short- and long-term learning and
memory function that persist well after exposure (Greene-
Schloesser and Robbins, 2012; Greene-Schloesser et al., 2013).
We have previously shown in rodent models that exposure
to radiation leads to long lasting reductions in neural stem
cell (NSC) proliferation, prolonged oxidative stress, inhibition
of neurogenesis, elevated CNS inflammation and cognitive
dysfunction (Acharya et al., 2009, 2010, 2011, 2014a,c; Lan
et al., 2012; Parihar et al., 2014a). While these factors are
likely to contribute to the disruption of CNS function, our
current understanding of the molecular and cellular mechanisms
underlying radiation-induced damage in the brain, and how they
impact neurocognition, are limited.
Astroglial activation is known to be a major consequence of
radiation-induced chronic injury (Zhou et al., 2011; Ballesteros-
Zebadua et al., 2012; Osman et al., 2014). Astrocytes form
complex networks by contacting thousands of synapses and
any disruption of astrocytic function following exposure to
radiation will disrupt the global homeostasis of the brain (Giaume
et al., 2010; Pannasch et al., 2011). Astrocytes also constitute
a ‘sink’ for the metabolic clearance of neurotransmitters and
the signaling molecule adenosine (Boison, 2007, 2008, 2009,
2013; Halassa et al., 2007). Adenosine is a ubiquitous modulator
of synaptic transmission and neuronal activity, exerting its
functions via activation of Gi/o protein coupled- A1 and A3
and Gs coupled A2A and A2B receptors (Boison, 2009, 2013;
Boison et al., 2010; Diogenes et al., 2014). Mechanisms and
physiologic functions of adenosine receptors have extensively
been studied (for details see: Boison, 2013). A shift in the A1/A2A
receptor ratio/activation during radiation-induced CNS injury
may reinforce the excitatory tone at synapses and contribute
to cognitive dysfunction. Therefore, adenosine regulates global
brain function under normal physiological settings and under
pathophysiological conditions to provide neuroprotection.
Due to the widespread distribution of adenosine receptors in
the brain, a tight regulation of endogenous levels of adenosine
is a necessity (Boison, 2007, 2008, 2009, 2013). Astrocytes play
a key role in regulating the levels of extracellular adenosine
through cytosolic adenosine kinase (ADK) (Boison, 2007, 2008,
2009, 2013). ADK, which phosphorylates adenosine to 5′-AMP, is
considered to be the key metabolic enzyme for the regulation of
extracellular adenosine in the brain (Lloyd and Fredholm, 1995).
Thus, inhibition or knockout of ADK leads to rapid increases
in extracellular adenosine, while overexpression of ADK leads to
a reduction of the synaptic adenosine tone. During astrogliosis,
ADK is overexpressed, thereby limiting the availability of
synaptic adenosine that fosters neurodegeneration (Boison, 2007,
2008, 2009, 2013). Thus, metabolic regulation of adenosine
by astroglial-synaptic compartments directly impacts neuronal
plasticity. Importantly, relatively little is known about the impact
of radiation-exposure on adenosine metabolism, astroglial and
synaptic function and its correlation with cognitive function. We
hypothesized that adenosine-dependent metabolic regulation is a
key mechanism in ionizing radiation-induced neurodegeneration
and cognitive dysfunction. Using a specific ADK inhibitor,
this proof-of-principle study delineates the protective role of
adenosine to attenuate radiation-induced cognitive decline.
MATERIALS AND METHODS
Animals, Irradiation and 5-ITU Treatment
All animal procedures described are in accordance with NIH
guidelines and approved by the University of California
Institutional Animal Care and Use Committee. Four month old
male athymic nude (ATN) rats (Cr:NIH-Foxn1rnu, strain 316;
Charles River, San Diego) were maintained in sterile housing
conditions (20◦C ± 1◦C; 70% ± 10% humidity; 12 h:12 h
light and dark cycle) and had free access to sterilized diet
and water. Rats were divided into 4 experimental groups (8–
10 animals per group): 0 Gy receiving vehicle (Con), 0 Gy
receiving 5-iodotubercidin, 5-ITU (Con+5-ITU), 10 Gy head-
only irradiation receiving vehicle (IRR) and 10 Gy head only
irradiation receiving 5-ITU (IRR + 5-ITU). Animals showing
signs of eye infection and/or neophobic behavior were excluded
from the study. In order to augment adenosine signaling
in the brain we decided to use a pharmacological approach
using the well-characterized ADK inhibitor 5-iodotubercidin
(5-ITU), which induces mild and transient sedation after
brain penetration. The use of a pharmacological agent allows
us to test a possible clinical route of therapeutic adenosine
augmentation and to prepare for future cell transplantation
approaches, which will require the use of immunocompromised
ATN rats, used in the present study. The ADK inhibitor 5-
ITU (HY-15424, NSC 113939, MedChem Express, Princeton,
NJ, USA) was made up fresh daily by dissolving in saline
with 2% ethanol (v/v, Sigma, St. Louis, MO, USA). Animals
received either vehicle (2% ethanol in saline, i.p.) or 5-ITU
daily (3.1 mg/kg, i.p.) for 6 days in order to precondition
the brain with neuroprotective adenosine. One hour after
the last 5-ITU injection, animals received 0 or 10 Gy head-
only X-rays. For cranial irradiation, animals were anesthetized
with isoflurane (5% for induction and 2% for maintenance
of anesthesia), placed ventrally on the treatment table (XRAD
320 irradiator, Precision X-ray, North Branford, CT, USA)
without restraint, and positioned under a collimated (1.0 cm2
diameter) beam for head-only irradiation delivered at a
dose rate of 1.10 Gy/min. 5-ITU dosing was based on our
previous studies (Fedele et al., 2005; Williams-Karnesky et al.,
2013). Neither irradiation nor 5-ITU treatment resulted in a
change in the body weight of animals. All behavioral and
immunohistochemical analyses were carried out at 1 month
post-irradiation.
Behavior Testing
To determine the effect of 5-ITU treatment on radiation-induced
alteration in hippocampal- and frontal cortex-dependent
cognition, rats from each group were subjected to cognitive
testing 1 month after irradiation. Behavioral testing was
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conducted over 3 weeks and included two open arena,
spontaneous exploration tasks (novel place recognition,
NPR and NOR) followed by a fear conditioning (FC) task.
Behavioral testing closely followed our previously described
protocols (Acharya et al., 2009, 2015a; Christie et al., 2012)
in immunocompromised animals. To avoid infections in our
strain of rats, we avoided water-based test paradigms such
as the Morris water maze and opted for NOR and NPR as
open arena tests. All behavioral testing data were collected
by independent, blinded observers and the average of these
data was used to compute the results for each task. Animals
were first subjected to the NPR task followed by the NOR
task. For the NOR and NPR tasks, the ‘head direction to zone’
function in Ethovision XT (Noldus) was used to track object
exploration. An animal was considered to be exploring an
object when its head was oriented toward it and its nose was
within a 1-cm radius. All experimenters were blinded to the
experimental condition and animal identification. Furthermore,
an additional observer blinded to all experimental conditions
re-scored the behavioral data (video files) thereby confirming
the automated tracking results of Ethovision XT independently.
The average of both scores was used to compute all behavioral
data. We did not observe animals climbing on the object or
any neophobic behavior. NPR and NOR data are presented as
a discrimination index (DI) and calculated as ([Novel location
exploration time/Total exploration time] – [Familiar location
exploration time/Total exploration time]) × 100. A positive
index indicates that rats spent more time exploring novelty (i.e.,
switched objects or locations), while a negative score indicates
that rats exhibited little or no preference for exploring novelty.
The FC task was administered in three sequential phases over
3 days including a training phase, a context test and a cue test
as described previously (Christie et al., 2012; Acharya et al.,
2015a).
Immunohistochemistry
Following completion of behavioral testing, animals
were euthanized and perfused (intracardiac) with 4%
paraformaldehyde (Acros Organics) made in phosphate buffered
saline (100 mM, pH 7.4, Gibco), brains were cryoprotected
(10–30% sucrose gradient) and sectioned coronally (30 µm
thick) using a cryostat (Leica Microsystems, Germany). For
the dual-immunofluorescence analysis of ADK and glial
fibrillary acidic protein (GFAP), the following antibodies
were used: rabbit anti-ADK (from the same batch that was
previously characterized and validated on knockout tissue;
Gouder et al., 2004), mouse anti-GFAP (EMD Millipore),
goat anti-rabbit or anti-mouse conjugated with Alexa Fluor
488 or 594 (Life Technologies/Invitrogen) and DAPI (Sigma–
Aldrich). Representative sections (3–4 sections/animal, four
animals/group) through the middle of the hippocampus were
selected for staining and stored in Tris-buffered saline (TBS,
100 mM, pH 7.4, Sigma–Aldrich) overnight. Free floating
sections were first rinsed in TBS followed by Tris-A (TBS with
0.1% Triton-X-100, Sigma–Aldrich), blocked with 10% normal
goat serum (NGS with Tris-A, Sigma–Aldrich) and incubated
overnight in a mixture of rabbit anti-ADK (1:3000) and mouse
anti-GFAP (1:500) antibodies prepared in 3% NGS and Tris-A.
The next day, the sections were treated with a mixture of goat
anti-rabbit Alexa Fluor 488 (1:750) and goat anti-mouse Alexa
Fluor 594 (1:500 dilution each) made with Tris-A and 3%
NGS for 1 h. The sections were light protected, washed with
Tris-A, and counterstained with DAPI nuclear dye (1 µmol/L
in TBS, 15 min) for visualization of hippocampal morphology.
Immunostained sections were rinsed in TBS and mounted
on clean gelatin coated slides using SlowFade Anti-fade Gold
mounting medium (Life Technologies/Invitrogen). ADK positive
cells were visualized under fluorescence as green and GFAP as
red fluorescence.
Confocal Microscopy, Image Processing and 3D
Quantification of Immunoreactivity
Immunostained sections were imaged using a laser-scanning
confocal microscope (Nikon Eclipse Ti C2) equipped with a 40×
PlanApo oil-immersion lens (1.3 NA) and an NIS-Elements AR
module (v4.30, Nikon). 30 z stacks (1024 bit depth) at 1 µm from
three different fields (318 µm × 318 µm area) in each section
were imaged from the dentate gyrus. ADK immunofluorescence
was imaged with 493 nm excitation and 518 nm emissions
and GFAP was imaged with 592 nm excitation and 617 nm
emissions. Images were deconvoluted using the AutoQuant
software (version X3.0.4, Media Cybernetics, Rockville, MD,
USA) with 1.26867 × 1.26867 × 1 µm spacing, and wavelengths
set at 447 nm (DAPI), 510 (ADK) and 594 nm (GFAP). An
adaptive, 3D blinded deconvolution method was used (Figure 3).
AutoQuant automatically creates and stores deconvoluted images
for direct import into the Imaris module (version 8.1.2, Bitplane,
Inc., Zurich, Switzerland). The 3D algorithm-based surface
rendering and quantification of fluorescence intensity for ADK
and GFAP were carried out in Imaris at 100% rendering quality.
Each channel was analyzed separately. 3D surface rendering
detects immunostained puncta (ADK) or cell processes [GFAP,
satisfying pre-defined criteria, verified visually for accuracy]
(Figure 3). A channel mean intensity filter was applied and
minimum thresholds were used for all the experimental groups.
The pre-set parameters were kept constant throughout the
subsequent analysis of ADK and GFAP immunoreactivity. The
quantification of astrocyte number (GFAP co-labeled with DAPI)
was facilitated using the Co-localization and the Spot tools of
Imaris module. ADK and GFAP data was expressed as a mean
immunoreactivity (percentage) relative to unirradiated controls.
The method is summarized in Figure 3.
Statistical Analysis
Statistical analyses were carried out using GraphPad Prism (v6).
One-way ANOVA was used to assess the normal distribution
of data and significance between control and irradiated groups
receiving either vehicle or 5-ITU treatment. When overall
group effects were found to be statistically significant, a
Bonferroni multiple comparisons test was used to compare
the IRR with individual experimental groups. For analysis of
FC data, repeated measures two-way ANOVA were performed.
All analyses considered a value of P ≤ 0.05 to be statistically
significant.
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FIGURE 1 | Adenosine kinase (ADK) inhibition by systemic 5-iodotubercidin (5-ITU) treatment protects against radiation-induced cognitive
dysfunction. Adult rats received 5-ITU (3.1 mg/kg, i.p., daily for 6 days) and were irradiated (0 or 10 Gy, head only) 1 h after the last injection. Animals were divided
into four experimental groups: 0 or 10 Gy whole brain irradiated receiving either vehicle or 5-ITU (Con, Con + 5-ITU, IRR, IRR+5-ITU). (A,B) 1 month post-irradiation,
animals were tested on spatial and episodic memory retention using the NPR and NOR tasks followed by fear conditioning (FC). The tendency to explore a novel
place (NPR) or object (NOR) was derived from the Discrimination Index (DI). (A,B) Whole brain irradiation (IRR) shows significant behavioral deficits on NPR and NOR
tasks compared to controls (Con and Con + 5-ITU) as indicated by impaired preference to a novel place or object. Irradiated animals treated with 5-ITU
(IRR + 5-ITU) show significant preference for the novelty when compared with irradiated (IRR) animals receiving vehicle. (C) 5-ITU treatment also improves behavior
on the hippocampal-dependent contextual FC task. The baseline freezing levels were comparable across groups, and all groups showed elevated freezing behavior
following a series of 5 tone-shock pairings. The context test was administered 24 h later, and IRR animals showed significantly decreased freezing compared to
controls (Con and Con + 5-ITU). Irradiated animals receiving 5-ITU showed a significant elevation in freezing behavior that was indistinguishable from the Con group.
Data are presented as mean ± SEM. (N = 8–10 animals/group). P-values are derived from ANOVA and Bonferroni’s multiple comparisons test. ∗∗∗P < 0.001;
∗∗P < 0.01; ∗P < 0.05 compared with the IRR group.
RESULTS
ADK Inhibition and Cognitive Function
Novel Place Recognition (NPR)
One month post-IRR, rats were habituated in an open field
arena and then tested on the NPR task (Figure 1A). The
ability to explore a novel spatial location on the NPR task
is dependent on intact hippocampal function (Save et al.,
1992; Mumby et al., 2002; Barker et al., 2007; Barker and
Warburton, 2011). The total exploration of both objects during
the familiarization and test phases were comparable between all
groups for this task. The DI was calculated to measure preference
or indifference for exploring novelty. A positive DI indicates
a preference, or more time exploring the novel place, while
a negative DI indicates indifference, or more time exploring
the familiar object. Following a 1 h retention interval between
the familiarization and test phases, a significant overall group
effect was found for the DI [F(3,28) = 5.88, P = 0.003] that
differed between the groups. In the test phase, IRR animals spent
significantly less time exploring the novel place compared to Con
(P = 0.001), Con + 5-ITU (P = 0.01) and IRR + 5-ITU groups
(P = 0.05, Figure 1A). Unirradiated animals receiving vehicle
(Con) or 5-ITU (Con + 5-ITU) treatment showed comparable
novel place exploration. Furthermore, after the 1 h retention
interval, irradiated animals treated with 5-ITU (IRR + 5-ITU)
did not differ from either Con or Con + 5-ITU animals.
These data indicate that ADK inhibition by 5-ITU treatment
prior to cranial IRR improved object location exploration on
the NPR task as compared to irradiated animals receiving
vehicle.
Novel Object Recognition
After NPR testing, rats were habituated and then tested on
the NOR task 1 month post-IRR (Figure 1B). Impairment
in prefrontal cortex and hippocampal function manifests as
an inability to discriminate a novel from a familiar object in
the NOR task (Barker et al., 2007; Barker and Warburton,
2011). The total exploration times for both objects were
not different between all experimental groups for this task.
In the test phase, a significant overall group difference was
found between the four cohorts for the DI [F(3,28) = 8.95,
P = 0.001]. After a 5 min retention interval between the
familiarization and test phases, Con and Con + 5-ITU rats
showed a preference for the novel object (Figure 1B). However,
irradiated rats receiving vehicle (IRR) showed a significantly
diminished preference to explore novel object compared to
either Con or Con + 5-ITU animals (P < 0.01). The novel
object exploration for the Con and Con + 5-ITU animals
did not differ. 5-ITU treated irradiated animals (IRR + 5-
ITU) exhibited significantly improved performance on the
NOR task compared to the IRR group (P = 0.01). The
DIs for Con, Con + 5-ITU and IRR + 5-ITU groups
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were statistically indistinguishable. Thus, 5-ITU treatment
improved novel object exploration behavior in irradiated
animals.
In summary, for each of the open arenas, episodic memory
tasks (NPR and NOR), a preference toward novelty (as indicated
by DI) was found to be significantly greater for Con, Con + 5-
ITU and IRR + 5-ITU groups in comparison with IRR group
(Figures 1A,B), demonstrating the protective effect of ADK
inhibition. These spontaneous exploration tasks (NPR, NOR)
rely on the innate curiosity of an animal to explore a ‘new
object placement’ or a ‘new object.’ Other factors such as
fatigue, depression and/or anxiety may also affect the overall
performance on these tasks, although differences in exploration
during either the habituation or familiarization phases of these
tasks were not found. To account for these possible confounds,
animals were subsequently tested in the FC task to interrogate
hippocampal function using a task not reliant on spontaneous
exploration.
Contextual Fear Conditioning (FC)
Three distinct phases of the FC task – training, context and
cue – were administered over 3 days. Group means and 95% CIs
for the post-training and context phases freezing (percent) were
as follows: Post-training Con (mean = 97.6, 95% CI = 95.0–
100.2); IRR (mean = 94.56, 95% CI = 88.66–100.5); Con + 5-
ITU (mean = 80.32; 95% CI = 69.10–91.54); IRR + 5-
ITU (mean = 82.17; 95% CI = 66.35–97.98); Context Con
(mean= 50.71, 95% CI= 32.88–68.54); IRR (mean= 20.68, 95%
CI= 9.34–32.02); Con+ 5-ITU (mean= 45.81, 95% CI= 34.78–
56.83); IRR + 5-ITU (mean = 51.11, 95% CI = 39.47–
62.75). Repeated measure (RM) ANOVA for the context phase
(Figure 1C) revealed significant differences between IRR and
Con groups (P = 0.001); between IRR and Con + 5-ITU
groups (P = 0.001) and between IRR and IRR+5-ITU groups
(P = 0.001). Groups did not differ significantly in the freezing
behavior across baseline, post-training, pre-cue and post-cue
phases (data not shown), indicating a selective deficit on the
hippocampal-dependent contextual memory phase of the task
(Phillips and LeDoux, 1992; Winocur et al., 2006). Irradiation
did not impair motor or sensory function, since all groups
demonstrated significant increases in freezing behavior after the
tone-shock pairings (post-training phase). Group means and
95% CIs for the cue phase (percent time freezing) were: Con
(mean = 91.53, 95% CI = 82.36–100.7); IRR (mean = 85.71,
95% CI = 66.72–104.7); Con + 5-ITU (mean = 84.48;
95% CI = 73.56–95.41); IRR+5-ITU (mean = 93.86; 95%
CI = 86.02-101.7). Thus, intact amygdala-dependent cued
memory acquisition of the tone-shock pairing was not impaired,
and that the deficit was specific to the hippocampal-dependent
contextual memory (Figure 1C) in which the pairing was learned.
Radiation-Induced Elevation in ADK and
Astrogliosis
To assess the impact of cranial irradiation on the status of
ADK and astrocytes, immunoreactivity for ADK and GFAP
was assessed via dual-immunofluorescence confocal microscopy
(Figure 2). Representative confocal micrographs revealed a
marked impact of cranial irradiation on ADK and GFAP
immunoreactivity. Compared to Con and Con + 5-ITU groups,
irradiated animals (IRR) showed increased expression of ADK
in the hippocampal granule cell layer (GCL), sub-granular zone
(SGZ) and dentate hilus (DH) at 1 month post-IRR (Figure 2B).
Concurrently, GFAP staining in unirradiated controls (Con and
Con + 5-ITU) show morphological characteristics consistent
with resting astrocytes (Figure 2C). Astrocytes in the IRR group
display enlarged cell bodies with thicker and longer processes;
this is consistent with hypertrophic, reactive astrocytes, or
astrogliosis (Figure 2C).
High resolution, 3D algorithm-based quantification of ADK,
GFAP and astrocyte number from the confocal z stacks
was facilitated by blinded deconvolution (AutoQuant) and
subsequent analysis using Imaris module (Figure 3). ADK and
GFAP quantitative immunofluorescence revealed a significant
increase in the immunoreactivity of the IRR group compared to
controls (Con and Con + 5-ITU, Figure 4). Cranial radiation
exposure (IRR group) significantly elevated ADK levels by
1.5 fold (P = 0.01 vs. Con and P = 0.02 vs. Con + 5-
ITU group) in the hippocampus 1 month after exposure
(Figure 4A). In parallel, hippocampal GFAP immunoreactivity
was elevated by ∼2 fold in the IRR group (P = 0.001,
Figure 4B) without a significant change in the total number of
astrocytes (Figure 4C) at 1 month. However, irradiated animals
receiving 5-ITU treatment (IRR + 5-ITU) showed a significant
reduction in ADK immunoreactivity (P = 0.02) and astrogliosis
(P = 0.001) throughout the hippocampus compared to IRR
animals. These qualitative (Figure 2) and quantitative (Figure 4)
data demonstrate that pharmacological ADK inhibition could
substantially protect against radiation-induced neuropathology.
DISCUSSION
Our findings demonstrate that adenosine’s well-known protective
role also extends to the attenuation of radiation-induced
cognitive impairments. Our previous data demonstrated
persistent, long-term cognitive impairments from 1 to 8 months
following a single IRR exposure (Acharya et al., 2014b, 2015b;
Parihar et al., 2014b, 2015), and suggest that global disruption
of homeostatic functions in the brain combine to compromise
cognitive performance over protracted post-IRR intervals.
Several neurodegenerative conditions (Alzheimer’s Parkinson’s,
ALS, epilepsy) share two key features with radiation-induced
neuropathology: (i) astrogliosis as a histopathological hallmark
and (ii) the onset of cognitive impairment (Bell and Zlokovic,
2009; Palop and Mucke, 2009; Aarsland and Kurz, 2010; Rusina
et al., 2010). Astrocytes play a key role in regulating the levels of
extracellular adenosine via cytosolic ADK to form a metabolic
reuptake system. Our data show that cranial irradiation
triggers astrogliosis and ADK overexpression 1 month after
exposure that could lead to enhanced metabolic clearance
of adenosine and resulting adenosine deficiency. Radiation-
induced synaptotoxicity, astrogliosis, and adenosine deficiency
in turn influence cognitive function (Boison and Aronica,
2015).
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FIGURE 2 | Cranial irradiation elevates adenosine kinase (ADK) immunoreactivity and astrogliosis. Immunofluorescence analysis demonstrates that at
1 month post-treatment, compared to controls (Con and Con + 5-ITU), exposure to cranial irradiation (10 Gy) leads to elevated ADK immunoreactivity (A,B; IRR
group; ADK, green; DAPI nuclear counterstain, blue) that is reduced to control levels in irradiated animals treated with 5-ITU (IRR + 5-ITU). Representative confocal
micrographs show the presence reactive astrocytic cell bodies (A,C; glial fibrillary acidic protein; GFAP, red) in the hippocampal dentate hilus (DH), sub-granular zone
and granule cell layer (GCL) indicating astrogliosis. IRR + 5-ITU animals showed reduced ADK and GFAP immunoreactivity compared to IRR animals. Scale bar:
30 µm.
Our data critically test our hypothesis that adenosine
augmentation prior to irradiation is protective against radiation-
induced neuropathology. Animals receiving the ADK-inhibitor
prior to cranial IRR were characterized by improved behavioral
performance as characterized in three distinct tasks to assess
cognitive function (Figure 1). Treatment with 5-ITU prior
to irradiation (IRR + 5-ITU) prevented development of
radiation-induced memory impairments on the NPR and NOR
tasks at 1 month post-exposure. In contrast to irradiated
rats receiving vehicle (IRR), DIs of irradiated animals with
5-ITU treatment (IRR + 5-ITU) were indistinguishable from
unirradiated controls, where both controls (Con) and 5-ITU
injected animals (Con + 5-ITU) showed significant preference
for exploring the novel place or object. Moreover, unirradiated
animals receiving 5-ITU were statistically indistinguishable from
the controls receiving vehicle. In these preventative studies
we chose a time point of analysis (4 weeks after irradiation),
which reflects the delayed onset of cognitive dysfunction after
radiation therapy (Tofilon and Fike, 2000) in combination with
the prophylactic use of an ADK inhibitor. Whether, prophylactic
ADK inhibition affects cognitive function at different time points
post irradiation, or whether post-irradiation treatment with an
ADK inhibitor might be of therapeutic benefit has not been
addressed here, but might be interesting to investigate in future
work.
The effectiveness of ADK inhibition to prevent radiation-
induced behavioral deficits was further confirmed using the
contextual FC task (Figure 1C) that engages the hippocampus
and does not rely on spontaneous exploration (Phillips and
LeDoux, 1992; Winocur et al., 2006). Irradiated animals (IRR)
spent significantly less time in freezing than Con and Con + 5-
ITU cohorts during the context phase of the FC task. These
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FIGURE 3 | Work flow of quantitative immunofluorescence. Blinded deconvoluted volume of z stacks (step 1) were uploaded into Imaris (v8.1.2) for
quantification of GFAP and ADK immunoreactivity (step 2). 3D algorithm-based Surface rendering of individual channels (pseudo-colored, steps 3–4) provide
quantitative analyses of fluorescence intensity (GFAP, ADK) and Spot tool and Co-localization modules provide quantification of the number of astrocytes (steps 4–5).
Data bin (step 6) provide quantitative immunofluorescence data for the individual channels. Scale bars: 5 µm.
data suggest that irradiation disrupted long-term (24 h) memory
for the tone-shock (context) association that has been shown
to rely on intact hippocampal function (Phillips and LeDoux,
1992; Winocur et al., 2006). Importantly, animals treated with
5-ITU prior to irradiation (IRR + 5-ITU) exhibited intact
freezing behavior, and were statistically indistinguishable from
Con and Con + 5-ITU animals in their contextual fear
memory. This finding indicates that radiation-induced deficits
in hippocampal-dependent long-term memory function may be
prevented by ADK inhibitor-induced adenosine augmentation
at the time of irradiation. The amount of post-training
freezing observed was comparable between all experimental
cohorts, suggesting that experimental procedures did not
affect initial acquisition of the conditioned freezing response
and memory consolidation. Similarly, irradiation or 5-ITU
treatments did not affect freezing behavior during the cue
test phase, indicating intact amygdala-dependent acquisition
and memory formation (Phillips and LeDoux, 1992; Winocur
et al., 2006). The specific deficits observed in contextual fear
memory tasks are consistent with the impairments in the NPR
and NOR tasks and suggest that cranial irradiation disrupts
hippocampal and frontal cortex function, and pre-IRR treatment
with an ADK inhibitor prevents radiation-induced cognitive
deficits.
Our data clearly show that pharmacological inhibition of
ADK can prevent a decline in cognition following cranial
irradiation. In the present study, we demonstrate that in
the irradiated brain (IRR), ADK is co-expressed in GFAP-
positive reactive astrocytes, which are characterized by a
hypertrophic morphology with larger soma and increased length
and width of astrocytic stellae compared to unirradiated
controls (Figures 2A,B). The total number of GFAP+
astrocytes did not differ between control and irradiated
groups (Figure 4C). These findings indicate that astrogliosis
is accompanied by ADK overexpression. Quantification
of ADK and GFAP immunoreactivity by high resolution
confocal microscopy showed a marked rise of fluorescence
intensity in the irradiated hippocampus (Figures 4A,B)
whereas, pre-treatment with the ADK inhibitor, 5-ITU,
prevented increases in ADK and GFAP immunoreactivity in
the irradiated brain. It is likely that pre-treatment with 5-ITU
attenuated the initial radiation-induced injury and therefore
the very processes that eventually cause increases in GFAP
and ADK immunoreactivity, although epigenetic mechanisms
(Williams-Karnesky et al., 2013; Boison, 2016) might also be
implicated. At the doses used, 5-ITU is not known to exert
any cytotoxic or apoptotic effects on astrocytes (Ugarkar et al.,
2000).
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FIGURE 4 | Treatment with 5-iodotubercidin (5-ITU) attenuated
radiation-induced elevation in adenosine kinase (ADK) and
astrogliosis. 3D algorithm-based deconvolution and quantification (Imaris,
Bitplane, Inc.) of ADK and glial fibrillary acidic protein (GFAP)
(Continued)
FIGURE 4 | Continued
immunoreactivity show that compared to controls (Con and Con + 5-ITU),
irradiation significantly increased the ADK (A) and astrogliotic cell bodies (B) in
the hippocampal dentate hilus, granule cell layer, sub-granular zone and
CA3/CA1 subfields. Compared with the irradiated cohort (IRR), animals
receiving 5-ITU (IRR + 5-ITU) had significantly lower ADK and GFAP
immunoreactivity in all hippocampal subfields. The reduced ADK and GFAP
immunofluorescence was comparable to controls (Con). The number of
astrocytes per hippocampal section did not change after irradiation or 5-ITU
treatment (C). All data are presented as mean ± SEM. (N = 4 animals per
group). ∗P < 0.02; ∗∗P < 0.01; ∗∗∗P < 0.001 compared with the IRR group
(ANOVA and Bonferroni multiple comparisons test).
Chronic inflammation is a hallmark of the irradiated brain
that is linked with cognitive decline (Zhao and Robbins, 2009;
Moravan et al., 2011; Belarbi et al., 2013; Acharya et al.,
2014c; Parihar et al., 2014a). Our results suggest that: (1)
increased ADK expression is associated with astrogliosis in the
irradiated brain; ADK-induced adenosine deficiency in turn may
contribute to the radiation-induced neuropathology, and (2)
chronic upregulation of ADK in the irradiated brain can be
prevented by the transient prophylactic administration of an
ADK inhibitor; this finding is in line with a lack of radiation-
induced cognitive impairments. Past studies have shown that
5-ITU was effective at increasing extracellular adenosine levels
in the brain (Pazzagli et al., 1995; Boison and Stewart, 2009;
Boison, 2013), and supports our current findings suggesting
that inhibition of ADK prior to irradiation is neuroprotective
through a similar mechanism. Inhibition of ADK reduced
synaptotoxicity in the hippocampus by modulating adenosine
receptors, indicating an important role of ADK in the regulation
of basal extracellular adenosine (Pazzagli et al., 1995; Gouder
et al., 2004; Boison and Stewart, 2009; Boison, 2013). (3)
Lastly, the contribution of ADK expression to radiomimetic
neuropathology would favor the development of adenosine-
based therapeutic interventions such as stem cell therapies to
augment adenosine signaling locally via transplanted adenosine
releasing cells.
CONCLUSION
Our experimental data support the overall concept that a
combination of neurotoxicity, astrogliosis, and elevation of
ADK, resulting in a deficiency of extracellular adenosine can
directly cause a broad spectrum of comorbid symptoms that
are collectively present across several neurological conditions
(Aronica et al., 2013; Boison and Aronica, 2015). If radiation-
induced adenosine deficiency, triggered by ADK upregulation,
is sufficient to precipitate neurocognitive impairments, then
therapeutic adenosine augmentation (molecular, cellular or
pharmacological) should ameliorate those symptoms. More
work is needed to assess whether a neuroprotective treatment
interferes with the therapeutic efficacy of radiotherapy or if
transient treatment with ADK inhibitors post-irradiation are as
effective as pre-irradiation treatments against radiation-induced
CNS dysfunction. ADK inhibitors represent some of the most
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promising adenosine elevating agents (Kowaluk et al., 2000;
McGaraughty et al., 2005; Boison, 2013). Our experimental data
support the concept that such therapeutic approaches might be
useful as prophylactic pre-treatment to avoid radiation-induced
cognitive impairment.
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